Israel: Study of >500,000 people shows 51% reduction in infections 13 days after first dose
— Eran Segal (@segal_eran) January 29, 2021
Consistent across age, sex, sector, or comorbidity, except for diabetes
Paper: https://t.co/U6Aa9NMNJi
"Might be an underestimation"
*** Multiple caveats (who got tested and more) *** pic.twitter.com/KBhvbhVQlD